Microbix Biosystems rolls out Quantdx product line

Executive Summary

• Microbix Biosystems Inc. has commercially launched Quantdx, a new line of well-characterized reference materials designed to support the development and validation of diagnostic assays.
• The initial launch includes over 80 reference materials covering six major infectious disease panels: fungal, human papillomaviruses, gastrointestinal, meningitis, respiratory, and sexually transmitted infections.
• The product is being introduced at ADLM 2025 in Chicago, with the company aiming to address unmet demand for high-quality, standardized reference materials in the diagnostics industry.

Key Details

• Product Name: Quantdx
• Product Description: Well-characterized reference materials that are accurately quantified and fully traceable, enabling assay developers to establish key analytical performance metrics including Limit of Detection (LoD), sensitivity (positive accuracy), and specificity (negative accuracy).
• Scope of Launch: Over 80 reference materials included in the initial launch.
• Target Applications: Covers six commonly tested disease panels:
  1. Fungal
  2. Human papillomaviruses
  3. Gastrointestinal
  4. Meningitis
  5. Respiratory
  6. Sexually transmitted infections
• Strategic Context: Quantdx complements Microbix's existing quality assessment products (QAPs) portfolio, specifically Proceedx (research use only) and Redx (in vitro diagnostic) controls.
• Launch Event: ADLM 2025 (Association for Diagnostic & Laboratory Medicine) in Chicago, United States, held July 28–31, 2025.
• Contact for Inquiries: [email protected]

Notable Quotes

• Cameron Groome, CEO and President: "The launch of Quantdx represents a strategic expansion of our capabilities to serve assay developers and clinical laboratories. By leveraging our in-house portfolio of organisms and expertise in nucleic acid quantification, we are confident in delivering reliable and reproducible reference materials to streamline assay development and validation."
• Phil Casselli, SVP of Sales and Business Development: "We are thrilled by the support we've received from prospective customers for Quantdx. It's clear that there is strong, unmet demand for high-quality and fully quantified reference materials across the diagnostics industry. We believe this launch will provide Microbix with more opportunities to support assay developers, clinical labs and manufacturers worldwide. We fully expect Quantdx to drive revenue growth and expand our global customer base."